Study S000711

Effect of Glucagon-like Peptide 1 Receptor Agonist in Combination with Insulin on Glycaemic Variability and Time-in-range in Diabetic Kidney Disease: a Randomised Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05218915
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 95
Start: 2022-01-28
Primary completion: 2024-10-30
Lead sponsor: Elaine Chow
Conditions: Diabetes Mellitus; Diabetic Kidney Disease
Interventions: DRUG:Dulaglutide; DRUG:Insulin Degludec; DEVICE:Continuous glucose monitor
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Glycemic variability [16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.